Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could eye drops replace needles for diabetic eye swelling?

NCT ID NCT06599684

Disease control Sponsor: Invirsa, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 21, 2026 · Updated 1 time

Summary

This small Phase 2 study tested INV-102 eye drops in 19 people with diabetic macular edema, a swelling in the back of the eye caused by diabetes. Participants used the drops daily for 8 to 12 weeks. The goal was to see if the drops could improve retinal health and reduce swelling. This is an early step toward a potential non-invasive treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
INV-102 ophthalmic solution (eye drops)
What this could lead to
If successful, this could lead to a simple eye drop treatment for diabetic macular edema, reducing the need for injections.
What could go wrong
This is a small, early-phase pilot study with only 19 participants. It may not show clear benefit, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

19 people

The number who actually took part.

Started

Sep 2024

Finished

Sep 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key Inclusion Criteria: * Male or female subjects ≥ 18 years of age and \< 76 years of age * Diagnosed with diabetes (Type 1 or 2) with hemoglobin A1c ≤ 12.0% * Study eye must have NCIDME (Part 1) or CIDME (Part 2) * Study eye must be moderate to severe NPDR Key Exclusion Criteria: * Prior laser treatment for DR in the study eye within 12 months from Screening Visit

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Center-involved diabetic macular edema are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

background diabetic retinopathy diabetic macular edema diabetic retinopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Center-involved diabetic macular edema Center-involved diabetic macular edema associated with non-proliferative diabetic retinopathy Diabetic retinopathy Non-center involved diabetic macular edema Non-center involved diabetic macular edema associated with non-proliferative diabetic retinopathy

Contacts and locations

Locations

  • MedTrials, Inc.

    Dallas, Texas, 75204, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.